A Long-term Safety Study of Once-daily Travatan

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Travoprost

Criteria

Adult patients of any race and either sex with chronic angle-closure glaucoma.